Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

Abstract Background Microtubule-associated protein Tau (MAPT) overexpression has been linked to poor prognosis and decreased response to taxane-based therapies in several cancer types, but its relevance in prostate cancer is unknown. Methods In this study, MAPT expression was analyzed by immunohisto...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Cornelia Schroeder, Jan Grell, Claudia Hube-Magg, Martina Kluth, Dagmar Lang, Ronald Simon, Doris Höflmayer, Sarah Minner, Eike Burandt, Till S. Clauditz, Franziska Büscheck, Frank Jacobsen, Hartwig Huland, Markus Graefen, Thorsten Schlomm, Guido Sauter, Stefan Steurer
Format:	Article
Language:	English
Published:	BMC 2019-03-01
Subjects:	MAPT Tau ERG PTEN Deletion Prostate cancer
Online Access:	http://link.springer.com/article/10.1186/s12885-019-5390-1